Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary signet-ring cell bladder adenocarcinoma].

F J Blasco Casares1, J M Saladié Roig, L Ibarz Servio

  • 1Servicio de Urología y Cirugía del Trasplante, Hospital de Badalona, Germans Trias i Pujol, Barcelona, España.

Archivos Espanoles De Urologia
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatological side effects of intravesical Mitomycin C: Delayed hypersensitivity.

Archivos espanoles de urologia·2016
Same author

Is polyomavirus BK the cause of hemorrhagic cystopathy in patients who undergo allogeneic hematopoietic progenitor cell transplantation?

Actas urologicas espanolas·2015
Same author

[Practical treatment approach of radiation induced cystitis].

Actas urologicas espanolas·2010
Same author

[Arteriovenous fistula of the renal stump after nephrectomy].

Actas urologicas espanolas·2007
Same author

[Cystic lymphangioma. Our experience].

Actas urologicas espanolas·2006
Same author

[Horse shoe kidney with congenital megacalyces and renal stone].

Actas urologicas espanolas·2006

This case study details a rare primary bladder adenocarcinoma in a 69-year-old male. The advanced signet-ring cell tumor infiltrated surrounding structures, proving untreatable.

Area of Science:

  • Uro-oncology
  • Gastrointestinal Pathology

Background:

  • Primary bladder adenocarcinoma is a rare malignancy, comprising 0.5-2% of all bladder tumors.
  • The patient had a prior history of urothelial carcinoma treated with transurethral resection (TUR) and intravesical chemotherapy.

Observation:

  • A 69-year-old male presented with a rare primary bladder adenocarcinoma.
  • The tumor exhibited extensive infiltration of adjacent anatomical structures.
  • Biopsy confirmed the presence of signet-ring cells, a histological subtype.

Findings:

  • The advanced stage and histological type of the adenocarcinoma indicated a poor prognosis.
  • The tumor's widespread infiltration rendered it untreatable with standard therapeutic approaches.

Implications:

Related Experiment Videos

  • This case highlights the diagnostic and therapeutic challenges posed by rare bladder adenocarcinomas.
  • Understanding the aggressive nature of signet-ring cell bladder tumors is crucial for patient management.
  • Further research into novel treatment strategies for advanced bladder adenocarcinoma is warranted.